Researchers are comparing near-death experiences (NDE) to psychedelics-imagined “death” experiences to learn more about both. The post Psychedelics...
BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine The post NICE says yes to BeiGene’s...
PITTSBURGH, Sept. 21, 2022 – Simple computer-based neurocognitive training—using positive words and pictures designed to boost self-worth—prolongs...
The article Small Pharma Completes Enrollment in Phase IIa DMT Trial was originally published on Microdose. Small Pharma has started the week with some...
A jump in research studies sparks increased educational programs. The post The Future Psychedelics Workforce is Getting Schooled Today appeared first on...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered...
Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. (OTCQX: NUMIF) recently acquired psychedelics...
ATMA Journey Centers Inc. (“ATMA”), an Alberta-based company focused on the international delivery of innovative psychedelic-assisted therapy solutions,...